1. 2013
  2. Lipoplexes carrying mRNA-encoding Gag protein modulate dendritic cells to stimulate HIV-specific immune responses. / De Haes, W.; Rejman, J.; Pollard, C.; Merlin, C.; Vekemans, M.; Florence, E.; De Smedt, S.C.; Grooten, J.; Vanham, G.; De Koker, S.; Van Gulck, E.

    In: Nanomedicine, Vol. 8, No. 1, 2013, p. 77-87.

    Research output: Contribution to journalA1: Web of Science-article

  3. Targeting of human antigen-presenting cell subsets. / Goyvaerts, C.; Dingemans, J.; De Groeve, K.; Heirman, C.; Van Gulck, E.; Vanham, G.; De Baetselier, P.; Thielemans, K.; Raes, G.; Breckpot, K.

    In: Journal of Virology, Vol. 87, No. 20, 2013, p. 11304-11308.

    Research output: Contribution to journalA1: Web of Science-article

  4. Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model. / Heyndrickx, L.; Stewart-Jones, G.; Jansson, M.; Schuitemaker, H.; Bowles, E.; Buonaguro, L.; Grevstad, B.; Vinner, L.; Vereecken, K.; Parker, J.; Ramaswamy, M.; Biswas, P.; Vanham, G.; Scarlatti, G.; Fomsgaard, A.

    In: PLoS ONE, Vol. 8, No. 9, 2013, p. e74552.

    Research output: Contribution to journalA1: Web of Science-article

  5. Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein. / Morellato-Castillo, L.; Acharya, P.; Combes, O.; Michiels, J.; Descours, A.; Ramos, O.H.; Yang, Y.; Vanham, G.; Ariën, K.K.; Kwong, P.D.; Martin, L.; Kessler, P.

    In: J Med Chem, Vol. 56, No. 12, 2013, p. 5033-5047.

    Research output: Contribution to journalA1: Web of Science-article

  6. Challenges and advances towards the rational design of mRNA vaccines. / Pollard, C.; De Koker, S.; Saelens, X.; Vanham, G.; Grooten, J.

    In: Trends in Molecular Medicine, Vol. 19, No. 12, 2013, p. 705-713.

    Research output: Contribution to journalA1: Web of Science-article

  7. Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines. / Pollard, C.; Rejman, J.; De Haes, W.; Verrier, B.; Van Gulck, E.; Naessens, T.; De Smedt, S.; Bogaert, P.; Grooten, J.; Vanham, G.; De Koker, S.

    In: Molecular Therapy, Vol. 21, No. 1, 2013, p. 251-259.

    Research output: Contribution to journalA1: Web of Science-article

  8. M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding. / Selhorst, P.; Grupping, K.; Tong, T.; Crooks, E.T.; Martin, L.; Vanham, G.; Binley, J.M.; Ariën, K.K.

    In: Retrovirology, Vol. 10, No. 12, 2013, p. 1-9.

    Research output: Contribution to journalA1: Web of Science-article

  9. Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate. / Visciano, M.L.; Tagliamonte, M.; Stewart-Jones, G.; Heyndrickx, L.; Vanham, G.; Jansson, M.; Fomsgaard, A.; Grevstad, B.; Ramaswamy, M.; Buonaguro, F.M.; Tornesello, M.L.; Biswas, P.; Scarlatti, G.; Buonaguro, L.

    In: Journal of Translational Medicine, Vol. 11, No. 165, 2013, p. 1-11.

    Research output: Contribution to journalA1: Web of Science-article

  10. 2012
  11. Ex vivo models of HIV sexual transmission and microbicide development. / Ariën, KK; Kyongo, JK; Vanham, G.

    In: Current HIV Research, Vol. 10, No. 1, 2012, p. 73-78.

    Research output: Contribution to journalA1: Web of Science-article

  12. Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine. / das Neves, J.; Michiels, J.; Ariën, K.K.; Vanham, G.; Amiji, M.; Bahia, M.F.; Sarmento, B.

    In: Pharmaceutical Research, Vol. 29, No. 6, 2012, p. 1468-1484.

    Research output: Contribution to journalA1: Web of Science-article

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 4718